Table 5. Physician-Reported Confidence in and Likelihood of Providing Guideline-Adherent Asthma Care After Participation in a Group Self-Assessment Module (SAM)
AgreementImmediately after SAM (n = 38)6 Months after SAM (n = 32)
The SAM helped me feel more confident in this area.
    Assessment of severityAgree/strongly agree10093.8
    Assessment of control (eg, using ACT or ATAQ)Agree/strongly agree94.796.9
    Planned visitsAgree/strongly agree10090.6
    Use of action plansAgree/strongly agree94.775.0*
    Environmental assessmentAgree/strongly agree94.780.7
    Use of inhaled steroids for persistent asthmaAgree/strongly agree100100
    Making the diagnosisAgree/strongly agree92.193.8
    Allergy evaluationAgree/strongly agree96.871.0
    Time constraints for evaluationAgree/strongly agree67.665.6
    Treatment gridsAgree/strongly agree96.884.4
At the end of this SAM, how likely were you to:Immediately after SAM (n = 38)6 Months after SAM (n = 25)
    Use inhaled corticosteroids as the preferred controller agent for treatmentLikely/very likely100100
    Begin planned asthma visits for patients with persistent asthmaLikely/very likely10092.0
    Assess severity based on EPR-3 criteriaLikely/very likely92.196.0*
    Assess control using the ACT or ATAQLikely/very likely94.788.0*
    Refer for allergy evaluationLikely/very likely84.280.0
    Seek an environmental assessment for persistent asthmaticsLikely/very likely89.584.0
  • * P < .05.

  • ACT, Asthma Control Test; ATAQ, Asthma Therapy Assessment Questionnaire; EPR-3, Expert Panel Report 3.